Clinical Trial Update: Intravenous Exenatide (Byetta) During Surgery [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating intravenous exenatide (Byetta) during surgery; results have been posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Euglycemia
• Hyperglycemia
• Hypoglycemia

Drugs mentioned

• BYETTA (Exenatide)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Euglycemia, Hypoglycemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-01-21